Health
18 Oct 2026
Liquidia Shares Rise After Legal Settlement With United Therapeutics
The biotech firm Liquidia regained investor confidence after settling a protracted legal dispute with United Therapeutics, clearing a key patent claim and allowing it to focus on its heart‑lung drug Yutrepia.
Read more